GILD

Gilead Sciences, Inc. Press Releases

$108.45
*  
2.91
2.76%
Get GILD Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
ONO and Gilead Announce Exclusive License Agreement to Develop BTK Inhibitor, ONO-4059, for the Treatment of B-cell Malignancies and Other Diseases
12/19/2014 1:00:00 AM - Business Wire
▲2.38 % Price Change since this news event. The Volume Ratio is 1.68.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Reveal Earnings Forecast for Apple, Halliburton, American Realty Capital Properties, Gilead Sciences, Zynga, and Bank of America
12/16/2014 8:45:00 AM - PR Newswire


Philippe C. Bishop, MD, to Join Gilead as Senior Vice President, Hematology and Oncology Therapeutics
12/15/2014 8:30:00 AM - Business Wire
▲3.04 % Price Change since this news event. The Volume Ratio is 1.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BetterInvesting Magazine Releases February Stock To Study And Undervalued Stock Choices For Investors'' Informational And Educational Use
12/9/2014 4:43:00 PM - PR Newswire
▲2.49 % Price Change since this news event. The Volume Ratio is 1.13.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council
12/9/2014 9:15:00 AM - PR Newswire


Gilead Presents Follow-up Data from Zydelig Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma
12/8/2014 10:00:00 AM - Business Wire
▲1.72 % Price Change since this news event. The Volume Ratio is 1.22.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Reveal Earnings Forecast for Gilead Sciences, Apple, Transocean, Halliburton, Ctrip, and Sirius XM
12/8/2014 8:45:00 AM - PR Newswire
▲3.41 % Price Change since this news event. The Volume Ratio is 1.22.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Reveal Earnings Forecast for Gilead Sciences, Kinder Morgan, JD.Com, Sirius XM, Apple, and Plug Power
12/4/2014 8:45:00 AM - PR Newswire
▲7.78 % Price Change since this news event. The Volume Ratio is 1.01.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Earnings Forecast Reports for Apple, Alibaba, Kinder Morgan, Gilead Sciences, Plug Power, and Yahoo
12/2/2014 8:45:00 AM - PR Newswire


Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries
12/1/2014 7:00:00 AM - PR Newswire


Reveal Earnings Forecast for Apple, Alibaba, Hewlett-Packard, Gilead Sciences, Petrobras, and BlackBerry
11/26/2014 8:45:00 AM - PR Newswire


Earnings Forecast Research for Kinder Morgan, Petrobras, Freeport-McMoRan, Keurig Green Mountain, Gilead Sciences, and Alibaba
11/24/2014 8:45:00 AM - PR Newswire


Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power
11/20/2014 8:45:00 AM - PR Newswire


European Commission Grants Marketing Authorization for Gilead’s Harvoni®? (Ledipasvir/Sofosbuvir), the First Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C Patients With Genotype 1 and 4
11/18/2014 10:07:00 AM - Business Wire


Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba
11/18/2014 8:45:00 AM - PR Newswire


Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
11/14/2014 8:45:00 AM - PR Newswire


Gilead Prices $4 Billion of Senior Unsecured Notes
11/12/2014 5:59:00 PM - Business Wire
▲1.17 % Price Change since this news event. The Volume Ratio is 1.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper
11/12/2014 8:45:00 AM - PR Newswire


Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C
11/11/2014 8:00:00 AM - Business Wire
▲0.79 % Price Change since this news event. The Volume Ratio is 0.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Gilead Announces Harvoni Study Results in Chronic Hepatitis C Patients with Advanced Liver Disease and Those Who Failed Prior Treatment
11/11/2014 8:00:00 AM - Business Wire
▲0.65 % Price Change since this news event. The Volume Ratio is 0.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Blue Line Protection Group Increases Its International Media Exposure With French Expose on Cannabis Industry
11/11/2014 8:00:00 AM - Market Wire


Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power
11/10/2014 8:45:00 AM - PR Newswire


Surveyed U.S. Specialists Perceive Gilead's Harvoni, the First Single-Tablet Regimen for Hepatitis C Virus Infections, As Having Key Advantages Over Emerging Treatment Options
11/6/2014 11:00:00 AM - PR Newswire


Gilead Submits New Drug Application to U.S. Food and Drug Administration for Tenofovir Alafenamide (TAF)-Based Single Tablet Regimen for HIV
11/6/2014 8:30:00 AM - Business Wire
▲1.47 % Price Change since this news event. The Volume Ratio is 0.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Earnings Forecast Buzz for Alibaba, GT Advanced Technologies, GoPro, Plug Power, Gilead Sciences, and American Realty Capital Properties
11/4/2014 8:45:00 AM - PR Newswire